✦ LIBER ✦

Denosumab: mechanism of action and clinical outcomes

✍ Scribed by D. A. Hanley; J. D. Adachi; A. Bell; V. Brown

Book ID: 117940537
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 279 KB
Volume: 66
Category: Article
ISSN: 1368-5031
DOI: 10.1111/ijcp.12022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fingolimod for Multiple Sclerosis: Mecha

Fingolimod for Multiple Sclerosis: Mechanism of Action, Clinical Outcomes, and Future Directions

✍ Matthias Mehling; Ludwig Kappos; Tobias Derfuss 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 125 KB

Skeletal and extraskeletal actions of de

Skeletal and extraskeletal actions of denosumab

✍ Sinningen, Kathrin; Tsourdi, Elena; Rauner, Martina; Rachner, Tilman D.; Hamann, 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 292 KB

Photopheresis: Clinical Applications and

Photopheresis: Clinical Applications and Mechanism of Action

✍ Rook, Alain H; Suchin, Karen Rebecca; Kao, David M F; Yoo, Elisa K; Macey, Willi 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 74 KB

Methylphenidate: Mechanism of Action and

Methylphenidate: Mechanism of Action and Clinical Update

✍ Lawrence Scahill; Deirdre Carroll; Kathleen Burke 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Clinical outcomes and mechanism of actio

Clinical outcomes and mechanism of action for rheopheresis treatment of age-related macular degeneration (AMD)

✍ Jose Pulido; Donald Sanders; Jeffrey L. Winters; Reinhard Klingel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB

The primary goals are to provide a comprehensive explanation of the potential role of therapeutic apheresis in the treatment of Age-Related Macular Degeneration (AMD). Initial clinical results with this technique and a summary of current literature that addresses the mechanism of action for the Rheo

Clinical Perspectives on Mechanism of Ac

Clinical Perspectives on Mechanism of Action

✍ JAN-OTTO OTTOSSON 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB